Determining the Efficacy and Safety of Acupuncture for the Preventive Treatment of Menstrual Migraine: A Protocol for a PRISMA-Compliant Systematic Review and Meta-Analysis
Qiqi Wu,Jiawei Wang,Xiaoqi Lin,Dexiong Han,Hantong Hu,Hong Gao
DOI: https://doi.org/10.2147/JPR.S394446
IF: 2.8319
2023-01-10
Journal of Pain Research
Abstract:Qiqi Wu, 1, &ast Jiawei Wang, 2, &ast Xiaoqi Lin, 2, &ast Dexiong Han, 3 Hantong Hu, 3 Hong Gao 3 1 Department of Acupuncture, Moxibustion and Massage, Wenzhou Central Hospital, Wenzhou City, People's Republic of China; 2 The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou City, People's Republic of China; 3 Department of Acupuncture and Moxibustion, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hantong Hu; Hong Gao, Department of Acupuncture and Moxibustion, the Third Affiliated Hospital of Zhejiang Chinese Medical University, No. 219 Moganshan Road, Xihu District, Hangzhou City, People's Republic of China, Email ; Background: Menstrual migraine (MM), as a common type of headache related to women's menstrual cycle, currently available treatments do not produce sufficient effectiveness, making it remains difficult to manage. Although acupuncture may be an effective treatment for MM, there is a lack of convincing evidence to recommend acupuncture to patients with MM until more solid evidence is produced. Therefore, the purpose of our systematic review (SR) and meta-analysis protocol is to synthesize up-to-date evidence regarding the clinical efficacy and safety of acupuncture on MM. Methods: To find qualifying RCTs, nine databases will be searched. RevMan 5.3 will be used to combine the retrieved data for meta-analyses. The Cochrane risk of bias instrument will be used to assess the methodological quality of each included trial. The strength and certainty of the evidence will be evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. Additionally, we will undertake sensitivity analyses, publication bias, and subgroup analyses if available. Discussion: Our SR and meta-analysis protocol will contribute to determining acupuncture's therapeutic effect and safety in the preventive treatment of MM. Based on the up-to-date evidence produced by the subsequent SR and meta-analysis, informed treatment decisions will be made by patients, physicians and policy makers. Keywords: menstrual migraine, acupuncture, systematic review, meta-analysis Migraine is a common chronic neurovascular disorder. According to the 2013 Global Burden of Disease survey from the World Health Organization (WHO), migraine was identified as the 3rd most common disease and was the 6th most disabling disease. 1,2 The International Headache Society defines migraine as an episodic headache that lasts from 4 to 72 h, concomitant with two of the following: throbbing pain, unilateral localization, aggravation by movement, moderate or severe intensity, and at least one of the following: nausea or vomiting, or photophobia and phonophobia. 3 The exact pathogenesis of migraine remains unclear, but the disorder may be associated with neurovascular dysfunction. 4 Migraine affects 18.9% of women worldwide, 5 and menstrual migraine (MM) is a special type of migraine associated with women's menstrual cycle. MM attacks often occur before the onset of menstruation, the symptoms are significantly worse during menstruation and are relieved after menstruation, and the frequency and symptoms of outbreaks tend to decrease during pregnancy or after menopause as hormone levels stabilized. 6,7 The headache of MM is often more severe than other types of migraine, with recurring attacks, usually lasting for 4~5 days, as long as the duration of menstruation, and is often accompanied by nausea, photophobia, irritability, depression, spontaneous sweating, stiff neck and vomiting. 8–10 It has been shown that MM is closely related to the ovarian cycle. 11 About 60% of female migraineurs report a link between migraine and menstruation. 12 Currently, the pathophysiological mechanisms underlying MM are not fully understood, but many studies suggest that due to the specific physiological cycle and genetic specificity of female migraine patients, the levels of sex hormones, especially estrogen, change periodically, along with changes in the function and morphology structure of nerve cells in the brain, and play an "analgesic" or "pain-causing" role in migraine under the influence of the internal and external environment. 13,14 The clinical diagnosis and treatment of MM are inadequate. Current treatment is mainly based on the migraine management model, which mainly includes acute treatment and preventive treatment. Acute treatment focuses on aborting migraine attacks, while pre -Abstract Truncated-
clinical neurology